medicalnewstoday.com
Doctor Knowledge Of Cancer Treatment Options, Costs Key To Advising On Proper Medical Care
03.07.2008 06:19
medicalnewstoday.com
The growing number of cancer treatment options and their widely varying costs suggest an increased need for oncologists to understand economic issues in cancer care and be able to discuss these issue with their patients, according to a study by researchers at the University of Texas M.D. Anderson Cancer Center and RTI International.
World
Cancer
Self-powered Implants For Injured Knees
03.07.2008 06:19
medicalnewstoday.com
As news of Tiger Woods' knee injury hits the headlines, a researcher at the University of Southampton has developed a new self-powered sensor to monitor progress during knee operations.
World
Orthopedics
ETH Zurich And IBM Improve Diagnosis Of Osteoporosis
03.07.2008 06:19
medicalnewstoday.com
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
World
Orthopedics
Fireworks Should Be Breathtaking, Not Bone-Shattering
03.07.2008 06:19
medicalnewstoday.com
Fourth-of-July fireworks always draw a crowd but those beautiful bursts of color can lead to catastrophic injuries if not used with care. This Independence Day, the American Academy of Orthopaedic Surgeons (AAOS) advises Americans to enjoy the spectacular celebrations but urges adults and children to exercise extreme caution by leaving fireworks to the professionals. According to the U.S.
World
Orthopedics
Low "Good" HDL Cholesterol Linked To Memory Decline
03.07.2008 06:18
medicalnewstoday.com
A new study from the UK suggests that low levels of the "good" HDL cholesterol is linked to poor memory, and decline in memory, in middle aged adults. The study is the work of researchers at University College, London, and is published in the 30th June issue of the Arteriosclerosis, Thrombosis and Vascular Biology journal of the American Heart Association.
World
Alzheimer's Disease
Brain 'trick' Offers Treatment Hope For Alzheimer's
03.07.2008 06:18
medicalnewstoday.com
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease. An ageing population means that neurodegeneration, such as Alzheimer's disease, is one of the major health problems in the developed world. But researchers at the University of York and Simon Fraser University in Burnaby, British Columbia, have designed an enzyme inhibitor which could 'trick' the brain and so help to halt neurodegeneration.
World
Alzheimer's Disease
Are Men Or Women More Likely To Have Memory Problems In Very Old Age?
03.07.2008 06:18
medicalnewstoday.com
Women over age 90 are significantly more likely to have dementia compared to men in their 90s, according to a study published in the July 2, 2008, online issue of Neurology®, the medical journal of the American Academy of Neurology. Research shows that dementia risk for both men and women increases from age 65 to 85, but this most recent study is one of few that looks at people over age 90.
World
Alzheimer's Disease
NPA Warns PCTs Not To Exploit Pharmacy As A Cash Cow In GP-Led Health Centers
03.07.2008 05:22
medicalnewstoday.com
The NPA has told PCTs planning new GP-led health centers to consider the impact on community pharmacy before rolling out plans for changes to their primary care infrastructure.
World
Pharmaceutics
Current Concepts In Clostridium Difficile Infection: A Focus On Recurrent Disease
03.07.2008 05:21
medicalnewstoday.com
Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI.
World
Infectious Diseases
Just Out - The Future Of Health And Nutrition Thru DNA Testing...
03.07.2008 05:21
medicalnewstoday.com
Discover the amazing future of health and nutrition through genetic and DNA testing - just out. This exciting new scientific breakthrough will make you look better, feel better, live longer and healthier lives. Learn the secrets and details about this health revolution, visit http://www.GeneWise4U.com which is completing their pre-launch campaign.
World
Genetics
This Summer Remember That Sunscreen Is No Longer Enough -- People Spending Time In The Sun Should Consider Sun Protective Clothing
03.07.2008 05:21
medicalnewstoday.com
Sunscreen has become a daily necessity for anyone spending time outdoors in the sun, especially during the hot summer months. Yet, very few people consider the protection afforded to them from their clothing. Clothing does protect the skin against the sun's harmful ultraviolet rays, but not all clothing provides the same protection.
World
Dermatology
Isolagen Completes Pivotal Efficacy Portion Of Phase III Studies Of Isolagen Therapy(TM) For Wrinkles
03.07.2008 05:21
medicalnewstoday.com
Isolagen(TM), Inc. (Amex: ILE) announced the completion of the pivotal efficacy portion of its Phase III clinical studies (IT-R-005/006) investigating the Isolagen Therapy(TM) for the treatment of nasolabial folds, or wrinkles. The last person in each study has completed the primary efficacy follow-up visit, and collation of this data has begun. The Company anticipates that top-line efficacy and safety data analyses from the studies will be reported in August 2008.
World
Dermatology
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
03.07.2008 05:20
medicalnewstoday.com
Abbott announced that the U.S. Food and Drug Administration (FDA) approved the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE V is the only drug eluting stent to have demonstrated superiority over Boston Scientific's TAXUS(R) paclitaxel-eluting coronary stent system in two randomized head-to-head clinical trials. XIENCE V will be launched in the United States immediately.
World
Cardiology
Texas Oncology Urges Texans To 'Save Your Skin:' Outsmart The Sun And Prevent Skin Cancer
03.07.2008 05:20
medicalnewstoday.com
Now that school is out and the first day of summer is upon us, the cancer care experts at Texas Oncology remind Texans to "save your skin" by outsmarting the sun when spending time outdoors. Although the most prevalent cancer in the United States today, skin cancer is also the most preventable. The majority of the more than 1 million annual U.S. cases of skin cancer are sun-related.
World
Cancer
Peregrine Pharmaceuticals Reports Positive Early Results In Phase II Study Of Bavituximab In Breast Cancer
03.07.2008 05:20
medicalnewstoday.com
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) reported that its lead product candidate bavituximab achieved the pre-specified Stage 1 primary endpoint in its ongoing Phase II clinical trial in patients with metastatic breast cancer. The trial is an open-label, Simon two-stage design to evaluate the safety and efficacy of a combination of bavituximab and docetaxel in metastatic breast cancer patients.
World
Cancer
English